Results 291 to 300 of about 157,199 (404)

Long-term effectiveness and safety of methotrexate-tacrolimus combination therapy versus methotrexate monotherapy in reducing rheumatoid arthritis flares after TNF inhibitor discontinuation: a retrospective cohort study. [PDF]

BMC Rheumatol
Naniwa T, Kajiura M.
europepmc   +1 more source

Long‐term remission of Hailey–Hailey disease by Er:YAG ablative laser therapy

Journal of the European Academy of Dermatology and Venereology, Volume 39, Issue 5, Page 1038-1045, May 2025.
Upper left panel: Hailey–Hailey lesion at baseline, directly after, 6 weeks and 3 years after a single Er:YAG laser ablation. Long‐term remission was noted in 75/77 Hailey–Hailey plaques after a median follow‐up of 38 months. Upper right panel: Median quality of life scores at baseline, 6 weeks and 3 years after laser ablation with a significant ...
Marie‐Eline P. H. Debeuf, Kèvin Knoops, Carmen López‐Iglesias, Eline Lookermans, Patty J. Nelemans, Myrurgia Abdul Hamid, Michel van Geel, Antoni H. Gostynski, Peter M. Steijlen, Marieke C. Bolling, Valerie L. R. M. Verstraeten   +10 more
wiley   +1 more source

A high intrapatient variability in tacrolimus exposure is associated with poor long‐term outcome of kidney transplantation

Transplant International, 2016
N. Shuker, L. Shuker, J. Rosmalen, J. Roodnat, L. C. Borra, W. Weimar, D. Hesselink, T. Gelder   +7 more
semanticscholar   +1 more source

Topical tacrolimus for the amelioration of breast cancer-related lymphedema (TACLE Trial): a study protocol for a randomized, double-blind, placebo-controlled phase II/III trial. [PDF]

Trials
Hansen FG, Jørgensen MG, Thomsen JB, Sørensen JA.   +3 more
europepmc   +1 more source

The use of tacrolimus (FK506) and antimetabolites as immunosuppressants for xenotransplantation across closely related rodent species [PDF]

, 1997
Demetris, AJ, Fung, JJ, Murase, N, Rao, AS, Starzl, TE, Valdivia, LA   +5 more
core  

Prediction of Drug–Drug Interaction between Tacrolimus and Principal Ingredients of Wuzhi Capsule in Chinese Healthy Volunteers Using Physiologically‐Based Pharmacokinetic Modelling

Basic & Clinical Pharmacology & Toxicology, 2018
Hongyan Zhang, F. Bu, Lei Li, Z. Jiao, Guo Ma, Weimin Cai, Xiaomei Zhuang, Hai-Shu Lin, Jae-Gook Shin, X. Xiang   +9 more
semanticscholar   +1 more source

Induction Therapy With Oral Tacrolimus Provides Long-Term Benefit in Thiopurine-Naïve Refractory Ulcerative Colitis Patients Despite Low Serum Albumin Levels. [PDF]

JGH Open
Igawa S, Inokuchi T, Hiraoka S, Toyosawa J, Aoyama Y, Yamasaki Y, Kinugasa H, Takahara M, Okada H, Otsuka M.   +9 more
europepmc   +1 more source

Management of human epidermal growth factor receptor inhibitors‐related acneiform rash: A position paper based on the first Europe/USA Delphi consensus process

Journal of the European Academy of Dermatology and Venereology, Volume 39, Issue 4, Page 730-741, April 2025.
Delphi Consensus on EGFRi‐induced acneiform rash: management guidelines on early diagnosis and grading, prophylactic and pre‐emptive treatment, reactive and personalized patient care. Abstract Background There is a need for unified guidance in the management of acneiform rash induced by epidermal growth factor receptor inhibitors (EGFRi) among ...
Z. Apalla, A. Freites‐Martinez, K. Grafanaki, A. Ortiz‐Brugues, V. Nikolaou, D. Fattore, P. Sollena, S. Deverapalli, S. Babakoohi, A. Galimont, N. Kluger, M. Beylot‐Barry, C. Larocca, C. Iriarte, J. Smith, I. Tattersall, R. Dodiuk‐Gad, M. Sauder, C. Carrera, B. Kwong, M. Whitley, N. Leboeuf, P. Romano, M. Starace, V. Mateeva, J. Riganti, J. Hirner, A. B. Patel, C. M. Reyes‐Habito, L. Kraehenbuehl, M. Kheterpal, M. Fida, J. Hassel, M. Lacouture, V. Sibaud   +34 more
wiley   +1 more source

Correction: Park et al. Protective Effects of Nargenicin A1 against Tacrolimus-Induced Oxidative Stress in Hirame Natural Embryo Cells. <i>Int. J. Environ. Res. Public Health</i> 2019, <i>16</i>, 1044. [PDF]

Int J Environ Res Public Health
Park C, Kwon DH, Hwang SJ, Han MH, Jeong JW, Hong SH, Cha HJ, Hong SH, Kim GY, Lee HJ, Kim S, Kim HS, Choi YH.   +12 more
europepmc   +1 more source

Darier disease: Current insights and challenges in pathogenesis and management

Journal of the European Academy of Dermatology and Venereology, Volume 39, Issue 5, Page 942-951, May 2025.
Darier disease (DD) is characterized by the following: Disrupted Ca2+ gradients, impaired desmosomes, impaired keratinocyte differentiation, type 17 inflammation, DC and LC ↓, Th17 cells ↑. DD treatment: First line: keratinocyte focused and/or anti‐inflammatory. Second line: experimental approaches like specific targeting of the inflammatory infiltrate.
Monika Ettinger, Susanne Kimeswenger, Isabella Deli, Judith Traxler, Sabine Altrichter, Petar Noack, Jakob D. Wikstrom, Emmanuella Guenova, Wolfram Hoetzenecker   +8 more
wiley   +1 more source